OTraces completes Phase II testing for blood test that detects breast cancer

[News]

OTraces, Inc., a Maryland-based biotech company developing blood tests for cancer diagnosis, announces completion of Phase II testing for a blood test that screens women for breast cancer.

More... (http://www.news-medical.net/news/20130410/OTraces-completes-Phase-II-testing-for-blood-test-that-detects-breast-cancer.aspx)